Combined assessment of phospholipase A2 receptor autoantibodies and glomerular deposits in membranous nephropathy

Journal of the American Society of Nephrology

Volumn 27, Issue 10, 2016, Pages 3195-3203

  Qin, Hua Zhang ^a   Zhang, Ming Chao ^a   Le, Wei Bo ^a   Ren, Qiang ^a   Chen, Da Cheng ^a   Zeng, Cai Hong ^a   Liu, Lei ^a   Zuo, Ke ^a   Xu, Feng ^a   Liu, Zhi Hong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIGEN; AUTOANTIBODY; IMMUNOGLOBULIN G4; PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; PHOSPHOLIPASE A2 RECEPTOR ANTIGEN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; PHOSPHOLIPASE A2 RECEPTOR;

ADULT; ALBUMIN BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN DEPOSITION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEINURIA; REMISSION; REPEAT PROCEDURE; TREATMENT RESPONSE; BIOPSY; BLOOD; IMMUNOLOGY; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AUTOANTIBODIES; BIOPSY; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; RECEPTORS, PHOSPHOLIPASE A2; RETROSPECTIVE STUDIES;

EID: 85011704961     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015080953     Document Type: Article

References (23)

1. Beck LH Jr., Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
2. Ronco P, Debiec H: Pathogenesis of membranous nephropathy: Recent advances and future challenges. Nat Rev Nephrol 8: 203-213, 2012
3. Kanigicherla D, Gummadova J, McKenzie EA, Roberts SA, Harris S, Nikam M, Poulton K, McWilliam L, Short CD, VenningM, Brenchley PE: Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int 83: 940-948, 2013
4. 2R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 9: 1386-1392, 2014
5. Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA: M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clin J Am Soc Nephrol 9: 1883-1890, 2014
6. 2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26: 2526-2532, 2011
7. Qin W, Beck LH Jr., Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z: Antiphospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22: 1137-1143, 2011
8. Ruggenenti P, Debiec H, Ruggiero B, Chianca A, Pellé T, Gaspari F, Suardi F, Gagliardini E, Orisio S, Benigni A, Ronco P, Remuzzi G: Antiphospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol 26: 2545-2558, 2015
9. Debiec H, Ronco P: PLA2R autoantibodies and PLA2R glomerular deposits inmembranous nephropathy.NEngl JMed 364: 689-690, 2011
10. Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA: Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serumreceptor antibodies in primary membranous nephropathy. Kidney Int 82: 797-804, 2012
11. Svobodova B, Honsova E, Ronco P, Tesar V, Debiec H: Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant 28: 1839-1844, 2013
12. Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA: Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 25: 1357-1366, 2014
13. Beck LHJr., Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ: Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response inmembranous nephropathy. J Am Soc Nephrol 22: 1543-1550, 2011
14. 2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6: 1286-1291, 2011
15. Fresquet M, Jowitt TA, Gummadova J, Collins R, O'Cualain R, McKenzie EA, Lennon R, Brenchley PE: Identification of amajor epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. J Am Soc Nephrol 26: 302-313, 2015
16. van de Logt AE, Hofstra JM, Wetzels JF: Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: Seroconversion after prolonged follow-up. Kidney Int 87: 1263-1264, 2015
17. Praga M, Barrio V, Juárez GF, Luño J; Grupo Español de Estudio de la Nefropatía Membranosa: Tacrolimus monotherapy in membranous nephropathy: A randomized controlled trial. Kidney Int 71: 924-930, 2007
18. McQuarrie EP, Stirling CM, Geddes CC: Idiopathic membranous nephropathy and nephrotic syndrome: Outcome in the era of evidencebased therapy. Nephrol Dial Transplant 27: 235-242, 2012
19. Ponticelli C, Passerini P, Altieri P, Locatelli F, Pappalettera M: Remissions and relapses in idiopathic membranous nephropathy. Nephrol Dial Transplant 7[Suppl 1]: 85-90, 1992
20. Tomas NM, Beck LH Jr., Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay AS, Debayle D, Merchant M, Klein J, SalantDJ, Stahl RA, LambeauG: Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl JMed 371: 2277-2287, 2014
21. Liu Z, Zhang H, Liu Z, Xing C, Fu P, Ni Z, Chen J, Lin H, Liu F, He Y, He Y, Miao L, Chen N, Li Y, Gu Y, ShiW, HuW, Liu Z, Bao H, Zeng C, ZhouM: Multitarget therapy for induction treatment of lupus nephritis: A randomized trial. Ann Intern Med 162: 18-26, 2015
22. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
23. Huang CC, Lehman A, Albawardi A, Satoskar A, Brodsky S, Nadasdy G, Hebert L, Rovin B, Nadasdy T: IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol 26: 799-805, 2013